Fig. 3From: New-onset graves’ disease after the initiation of nivolumab therapy for gastric cancer: a case reportClinical course of the patient. MMI: methimazole, KI: potassium iodide. Day 0: first administration of nivolumab, Day 21: second administration of nivolumabBack to article page